Cargando…
Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy
Tuberculosis (TB) is top infectious disease killer caused by a single organism responsible for 1.5 million deaths in 2018. Both COVID-19 and the pandemic response are risking to affect control measures for TB and continuity of essential services for people affected by this infection in western count...
Autores principales: | Musso, Maria, Di Gennaro, Francesco, Gualano, Gina, Mosti, Silvia, Cerva, Carlotta, Fard, Saeid Najafi, Libertone, Raffaella, Di Bari, Virginia, Cristofaro, Massimo, Tonnarini, Roberto, Castilletti, Concetta, Goletti, Delia, Palmieri, Fabrizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811686/ https://www.ncbi.nlm.nih.gov/pubmed/33454928 http://dx.doi.org/10.1007/s15010-021-01576-y |
Ejemplares similares
-
Common and Rare Hematological Manifestations and Adverse Drug Events during Treatment of Active TB: A State of Art
por: Minardi, Maria Letizia, et al.
Publicado: (2021) -
Increased Association of Pulmonary Thromboembolism and Tuberculosis during COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital
por: Di Bari, Virginia, et al.
Publicado: (2022) -
Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital
por: Di Gennaro, Francesco, et al.
Publicado: (2021) -
Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection
por: Najafi-Fard, Saeid, et al.
Publicado: (2023) -
Hepatitis C virus infection: a challenge in the complex management of two cases of multidrug-resistant tuberculosis
por: Musso, Maria, et al.
Publicado: (2019)